Wnt/ß-catenin signalling modulates the timing of cell fate decision making in the early mouse embryo


Por: Lilao-Garzón, J, Corujo-Simon, E, Vinyoles, M, Fischer, SC, Guillén, J, Balayo, T and Muñoz-Descalzo, S

Publicada: 6 mar 2026
Resumen:
Cell fate choice is a key event happening during preimplantation mouse development. From embryonic day 3.5 (E3.5) to E4.5, the inner cell mass (ICM) differentiates into epiblast (Epi, NANOG expressing cells) and primitive endoderm (PrE, GATA6, SOX17 and/or GATA4 expressing cells). The mechanism by which ICM cells differentiate into Epi cells and PrE cells remains partially unknown. FGF/ERK has been proposed as the main signalling pathway for this event, but it does not explain co-expression of NANOG and GATA6 or how the cell fate choice is initiated. In this study, we investigate whether Wnt/beta-catenin signalling also plays a role. To this end, we use two in vitro models based on inducible GATA6 expression: one in 2D (flat cultured cells), and another in 3D, namely ICM organoids. By combining these in vitro models with in vivo mouse embryos, chemical and classical genetics, and quantitative 3D immunofluorescence analyses, we propose a dual role for Wnt/beta-catenin signalling. We find that beta-catenin, acting alongside FGF/ERK signalling, helps to guide the cell fate choice towards PrE. Additionally, by regulating GATA6 and GATA4 stability, Wnt/beta-catenin signalling further facilitates this choice. To summarise, we observe that Wnt/beta-catenin signalling pathway activation promotes PrE differentiation, while its inhibition delays it.

Filiaciones:
Lilao-Garzón, J:
 Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Las Palmas Gran Canaria, Spain

 Univ Bath, Dept Biol & Biochem, Bath, England

 Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA

Corujo-Simon, E:
 Univ Bath, Dept Biol & Biochem, Bath, England

 Univ Edinburgh, Western Gen Hosp, Inst Genet & Canc, MRC Human Genet Unit, Edinburgh, Scotland

:
 Univ Cambridge, Dept Genet, Cambridge, England

 Univ Barcelona, Josep Carreras Leukemia Res Inst, Sch Med, Dept Biomed, Barcelona, Spain

Fischer, SC:
 Julius Maximilians Univ Wurzburg, Fac Biol, Ctr Computat & Theoret Biol, Wurzburg, Germany

Guillén, J:
 Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Las Palmas Gran Canaria, Spain

Balayo, T:
 Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Las Palmas Gran Canaria, Spain

 Univ Pompeu Fabra, Syst Bioengn, MELIS, Barcelona, Spain

Muñoz-Descalzo, S:
 Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Las Palmas Gran Canaria, Spain

 Univ Bath, Dept Biol & Biochem, Bath, England
ISSN: 19326203





PLoS ONE
Editorial
Public Library of Science, 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 21 Número: 3
Páginas:
WOS Id: 001708302500024
ID de PubMed: 41790751
imagen Green Submitted, gold

MÉTRICAS